Me&'s Tech Brings Innovation to the Infant Formula Category
Laura McQuarrie — November 24, 2022 — Life-Stages
References: meand.au & greenqueen.hk
Me& is developing cell-based breast milk with cellular and molecular technology to create a world-first innovation. The cell-based fortified human milk is based at the Hudson Institute of Medical Research in Melbourne, an institute that is recognized as a world leader in medical research on infant and child health and development.
This technology is poised to disrupt the infant formula category and it has the potential to address a global lack of supply for human milk to support preterm and newborn babies. "My inspiration for this business is to fill this much-needed gap, and reduce the reliance on cows’ milk that we know is not good for babies, the environment or the animals," said Esha Saxena, Me& co-founder.
Me&, Australia's first cell-based milk start-up, recently closed an oversubscribed $2.5 million seed round led by Horizons Ventures and CSIRO Fund Main Sequence, and Better Bite Ventures is also participating.
This technology is poised to disrupt the infant formula category and it has the potential to address a global lack of supply for human milk to support preterm and newborn babies. "My inspiration for this business is to fill this much-needed gap, and reduce the reliance on cows’ milk that we know is not good for babies, the environment or the animals," said Esha Saxena, Me& co-founder.
Me&, Australia's first cell-based milk start-up, recently closed an oversubscribed $2.5 million seed round led by Horizons Ventures and CSIRO Fund Main Sequence, and Better Bite Ventures is also participating.
Trend Themes
1. Cell-based Breast Milk - The development of cell-based breast milk technology to create a world-first innovation can disrupt the infant formula category.
2. Fortified Human Milk - The use of cellular and molecular technology to create fortified human milk could address the global lack of supply for human milk to support preterm and newborn babies.
3. Reducing Reliance on Cows' Milk - The push to reduce reliance on cows’ milk that is known to be not good for babies, the environment or the animals is creating opportunities for innovation in the infant formula industry.
Industry Implications
1. Infant Formula - The development of cell-based breast milk technology and fortified human milk has the potential to disrupt and transform the infant formula industry.
2. Biotechnology - The use of cellular and molecular technology to create cell-based breast milk and fortified human milk presents disruptive innovation opportunities for the biotechnology industry.
3. Medical Research and Development - The development of cell-based breast milk and fortified human milk has the potential to transform medical research and development in the field of infant and child health and development.
5.9
Score
Popularity
Activity
Freshness
